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A. Frankel*Renal Business Office, West London Renal and Transplant Centre, Hammersmith Hospital, London, UKThe use of central venous catheters for temporary vascular access is a vital part of modern medicine and has an important
role in the management of patients with renal failure. Attention to detail when addressing issues relating to temporary
venous access, will pay dividends, with significant reductions in morbidity and mortality in both the short and long term..
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Whilst obtaining access to the circulation is a routine
practical procedure in medicine, the use of central
venous catheters has significant morbidity. However,
this can be minimised by an understanding of the
principles of good practice, together with attention to
detail. This article concentrates on haemodialysis
associated temporary vascular access but the many
of the points made can be generalised to other forms of
central venous access, such as in the ITU setting, for
the administration of intravenous nutrition or in the
general medical ward.
Successful haemodialysis requires satisfactory
access to the patient’s circulatory system, in order to
pump blood through an artificial kidney, at speeds of
greater than 350 ml/min. This need has resulted in the
development of larger and more sophisticated access
devices and to improvements aimed to reduce
complications. The world haemodialysis population
has grown significantly in the last 10 years and is
predicted to grow even further in the coming 10 years
(Fig. 1). While vascular access in these patients is
usually geared toward the provision of long-term
native arterio-venous fistulae, there are a number of
situations in which urgent access to the circulation is
required and this is usually achieved by the use of
dialysis catheters. Such catheters are unavoidable for:
(1) Patients who present with reversible deterioration
in kidney function requiring temporary dialysis.ng author. Dr A. Frankel, Consultant Nephrologist,
ss Office, West London Renal and Transplant Centre,
h Hospital, Ducane Road, London W12 OHS, UK.
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0417+ 06 $35.00/0 q 2005 Elsevier Ltd. All rights reser(2) Patients whose end stage renal failure has not been
previously diagnosed, and who require dialysis as
an emergency or whilst awaiting the formation or
maturation of permanent vascular access.
(3) As a bridging modality when a patient’s access has
failed, whether that be permanent vascular access,
or peritoneal dialysis.
It is unlikely that these three groups of patients will
reduce in size in the future (unheralded chronic renal
failure still accounts for between 20 and 50% of
patients entering UK end stage renal failure pro-
grammes) and high quality management of temporary
venous access will remain a major necessity for
nephrologists.
Older forms of temporary access such as the
Scribner shunt have now virtually disappeared from
most modern units, and dialysis catheters have
become the ‘norm’. The design of haemodialysis
catheters has evolved over time, since first introduced
in the late 1960’s.1 These design changes have occurred
in response to the demands of the dialysis community
and particularly in relation to the requirement for high
volume blood flows and reduced infection rates.Catheter Design
The original catheters used for haemodialysis con-
sisted of two separate single lumen catheters. These
were rapidly replaced by dual lumen catheters, which
have two co-axial lumens within a single catheter, with
the arterial port about 3 cm proximal to the venous
port. The recently introduced Tesio catheter hasEur J Vasc Endovasc Surg 31, 417–422 (2006)
doi:10.1016/j.ejvs.2005.10.003, available online at http://www.sciencedirect.com onved.
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Fig. 1. Incidence rates of ESRD by diagnosis in the USA for
the 10 year period (1989–1998).
A. Frankel418reverted to the original concept of two separate single
lumen catheters, with two individual tubes lying
freely within the vein (Fig. 2). The major change in
the catheter design over the last 20 years has been the
development and increasing use of catheters that can
be percutaneously tunnelled (usually with cuffs) and
which are more suitable for long-term use. The terms
acute and chronic access catheters are sometimes used
synonymously with non-tunnelled and tunnelled
catheters, respectively, but this is a misnomer since
tunnelled central venous catheters have as much of a
role in temporary access management, as a non-
tunnelled catheter (Fig. 3).
Most modern dual lumen haemodialysis catheters
are formed from polyurethane, which is stiff at room
temperature, but which softens at body temperature.
These catheters are easy to insert by the percutaneous
Seldinger technique. In contrast, soft silicone catheters
must be inserted using a peel-away sheath. There are
variations in lengths of catheter from tip to hub and
also in catheter diameters and there is an increasing
move to the use of larger bore catheters, to allow blood
flows in excess of 350 ml/min for high efficiency
haemodialysis. Much of these design variations areFig. 2. Design of central venous catheter has developed over
the last 10 years (a) ASH split catheter design, (b) standard
tunnelled catheter with cuff (c) standard non-tunnelled
catheter.
Eur J Vasc Endovasc Surg Vol 31, April 2006only important if the catheter is required to provide
haemodialysis access for longer than 2 weeks.
Otherwise, the cheaper non-tunnelled catheters are
perfectly adequate for shorter periods of
haemodialysis.Insertion
There are significant complications associated with
haemodialysis catheter insertion that vary with the site
of the insertion and the catheter type. It is essential that
those who undertake central venous catheter insertion
should have been appropriately trained and are
familiar with its potential complications. Catheter
insertion should not automatically be delegated to
the most junior member of the team.
The use of real time ultrasound to visualise the vein
at the time of insertion is known to reduce the
incidence of complications in trained hands (Fig. 4).2
Both the National Institute of Clinical Excellence in the
UK and the USA KDOQI recommend ultrasound
guidance as the preferred method for insertion of
central venous catheters into the internal jugular vein
(special adapters for ultrasound probes are available
for use in subclavian vein catherisation).
The site for insertion of a temporary dialysis
catheter must take into account its associated compli-
cations and risks. The femoral and the internal jugular
sites are the easiest for central vein catheter insertion,
while the subclavian catheterisation has the highest
incidence of complications. Unfortunately infection
rates for non-tunnelled femoral and internal jugular
catheters are higher than for subclavian vein catheters,
although for tunnelled lines this problem is less of an
issue.3,4 The use of the left internal jugular vein carries
difficulties in regard to both complications and
placement, as the catheter has to traverse two 908
bends to reach the right atrium (Fig. 5).
It is important to ensure that the catheter tip is
appropriately positioned within the right atrium for
soft silicone based tunnelled catheters, or at the
junction of the SVC with the right atrium for non-
tunnelled polyurethane catheters (in order to avoid the
stiffer material damaging the right atrial wall).
There is a high incidence of central vein stenosis
and occlusion in patients with subclavian catheters,
which may seriously compromise the subsequent
ability to form an AV fistula for long-term dialysis
access in that arm.5 The loss of the access sites of one
arm is of considerable importance for that patient’s
long-term outcome, even with the development of
surgical and radiological techniques to decompress
the stenoses. Whether the left internal jugular route
Fig. 3. The tunnelled haemodialysis catheter provides a
means of both temporary and long-term access to the
patient’s circulation. Fig. 5. Anatomical representation of the route taken by a
catheter inserted into the left internal jugular vein, illustrat-
ing the double right angle route required.
Temporary Access and Central Venous Catheters 419carries a similar risk of central vein stenosis has yet
to be substantiated, as the number of patients with left
internal jugular catheters in the early studies was
small.5,6
There are a number of alternative routes that can be
used in patients who have run out of access, or have
central vein stenosis. These include direct placement
of the central venous catheter in the right atrium, the
use of trans-lumbar IVC placed catheters. These are
usually used as a last resort, and experience in these
techniques is low in most renal units but co-operation
across units could allow radiological expertise to be
developed on a regional basis.
The most appropriate strategy for temporary
haemodialysis access management depends on the
anticipated duration of treatment. If this is likely to be
less than one week and the patient is hospitalised, a
femoral catheter should be considered, although thisFig. 4. The SITE RITE 3e is one of the ultrasound devices
available, which allows real time visualisation of the internal
jugular vein. The images obtained allow clear definition of
the internal jugular vein and its relationship to the carotid
artery.carries a significant risk of infection, and also of
femoral vein stenosis and thrombosis. For these
reasons it is often best to rotate the catheter every
48–72 h, and to use anti-embolic prophylaxis with TED
stockings and subcutaneous heparin. If treatment is
likely to be limited to 1–2 weeks, with a reasonable
expectation of recovery of kidney function or the
maturation of a permanent vascular access, a right
internal jugular non-tunnelled catheter is an option.
However, for those in whom treatment is expected to
extend beyond 2 weeks, it is probably best to start with
a non-tunnelled femoral catheter followed by the early
insertion of a tunnelled, internal jugular catheter
(usually on the dominant side, to preserve the non-
dominant arm for a native AV fistula).Infection and Central Venous Catheters
The major complication of central venous catheters is
infection. Numerous studies have confirmed that the
risk of both local and blood-borne infections is greater
in patients with central venous catheters than those
with an AV fistula.7 The incidence of infection is
greater for non-tunnelled, as opposed to tunnelled
catheters and is related to the duration of placement
(Table 1). Tesio catheters have been reported to have
reduced infection rates, and this has led some units to
use them routinely for long-term haemodialysis
access.8
Catheter-associated infection is a major problem,
which can result in septic central vein thrombosis,
infective endocarditis, osteomyelitis, septic arthritisEur J Vasc Endovasc Surg Vol 31, April 2006
Table 1. Event rate for infectious complications by access type (Dx surveillance network, October 1999–May 2001-Ref. [6])
Access infections (events) Access infections per 100 patient months
Autogenous fistulae 130 0.56
Prosthetic graft 421 1.36
Tunnelled catheter 1594 8.42
Non-tunnelled catheter 284 11.98
All access 2429 3.2
A. Frankel420and death. Furthermore, indwelling long-term artifi-
cial material in immuno-compromised patients such
as those on renal dialysis, and who are receiving a
variety of antibiotics, provides a rapid breeding
ground for the development of resistant organisms.
As a result, many of the more serious multi-resistant
organisms have first appeared on haemodialysis units.
The high rate of infection not only increases
morbidity and mortality, but also has significant
economic implications, as infection is the commonest
reason for the admission of haemodialysis patients to
hospital.
The reduction in the incidence of infection is a major
priority of all those using central venous catheters in
haemodialysis units, intensive therapy units and
within parenteral nutrition programs. Infection can
spread either along the inner lumen of the catheter or
along the outside of the catheter:
† Infection or colonisation at the exit site is followed
by spread down the outside of the catheter
resulting in either a tunnel infection in those with
tunnelled lines, or blood-borne infection in those
with non-tunnelled lines.
† Colonisation of the internal wall of the catheter is a
frequent occurrence and is usually associated with
the presence of a biofilm. This is produced by a
combination of host factors (e.g. fibrinogen and
fibrin) and microbial products (e.g. glycocalyx).
Within the biofilm the colonising bacteria convert to
a sessile form and live in symbiosis with the
patient. What determines the development of
overt infection is not clearly understood although
the concentration of organisms is probably
relevant.
The prevention of infection is directed to each of
these two portals of entry and a number of guidelines
and recommendations have been produced in this
rapidly developing field.9
Scrupulous aseptic care, at the time of insertion is
vital and use of prophylactic antibiotics is of particular
relevance to patients who are undergoing insertion of
a tunnelled catheter. Prevention of exit site infection
requires regular review of the exit site and aseptic
dressing change. There is also evidence to support theEur J Vasc Endovasc Surg Vol 31, April 2006use of either chlorhexidine and povidine iodine as
cleaning materials, both of which reduce the risk of
exit site infections and subsequent septicaemia.10
Unfortunately, many of these agents are alcohol
based, which can result in catheter damage, but this
is more important for long term tunnelled haemodia-
lysis catheters than for non-tunnelled catheters, which
are likely to be removed within a short period of time.
Mucocutaneous colonisation with specific Gram-
positive bacteria such as Staphylococcus aureus (S.
aureus) is associated with an increased risk of exit
site infection and subsequent blood borne infection. S.
aureus is the most significant organism associated with
central venous catheter infections and is highly
virulent, frequently leading to osteomyelitis and
endocarditis, which can be quite aggressive and
difficult to treat (the question of methicillin sensitivity
is of relevance only to the treatment, but not to the
morbidity). Because of this, colonisation should be
routinely assessed and treated. Intra nasal mupirocin
cream should be used for nasal carriers of S. aureus,
and may also benefit patients with tunnelled PD
catheters.11
The application of mupirocin to the exit site to
prevent colonisation with S. aureus and staphylococcal
septicaemia has been controversial but there are now
sufficient studies to recommend its routine use.12
There has been concern that this could result in
mupirocin resistance but this seems to have a low
incidence in practice and remains clinically unim-
portant. Moreover, there does not appear to be any
increase in non-staphylococcal infections.
A number of methods have been tried to reduce the
spread of infection along the lumen of the catheter.
These include the impregnation of the catheters with
antibacterial agents, such as silver or antibiotics, which
have been found to prevent infections, particularly in
ITU but has the risks of patient sensitivity and the
development of bacterial resistance. Antibiotic
impregnation has been utilised mainly for non-
tunnelled catheters and has been associated with a
significant reduction in infection in the short term.13
Antibiotic locks have also been tried, and there is
some evidence that gentamicin locks reduce the rate of
infection with both tunnelled and non-tunnelled
catheters.14 Concerns of resistance and toxicity have
Temporary Access and Central Venous Catheters 421so far proven to be unfounded. More recently,
taurolidine citrate has been developed as both an
anti-thrombotic and anti-bacterial agent. There is some
evidence supporting its use as an anti-thrombotic
agent and that it reduces the incidence of septicaemia
or bacteraemia but not exit site colonisation and
infection.15 Further studies are required before either
of these techniques can be recommended for routine
use with tunnelled catheters.
It is important for individual units to monitor their
local infection rate and the bacterial spectrum, which
may depend upon environmental factors such as
dialysis water purity.
Treatment of catheter related infection depends on
catheter type and the site of infection. Significant exit
site infection in a non-tunnelled catheter should
prompt consideration for its removal. Antibiotic use
should be judicious and take into account both
national guidelines and local resistance patterns to
reduce the development of antibiotic resistance.
Vancomycin use should be minimised. For tunnelled
catheters, which are more difficult to change, exit site
infections may be treated with local agents and
appropriate antibiotics but full-blown tunnel infec-
tions, especially with S. aureus, may prove difficult to
treat and removal of catheter is usually required.
Where there is evidence of blood borne infection in
patients with temporary lines, the catheter should be
removed at the earliest opportunity and appropriate
antibiotic treatment commenced. For tunnelled cath-
eters, initial empiric antibiotic regimes should be
started and the catheter only removed if markers of
infection (fever, white cell count or CRP) have not
improved within 48 h. Some such catheters may be
salvageable although a prolonged antibiotic course is
often required.Catheter Function
The role of haemodialysis catheters is to provide
sufficient access to the circulation to allow blood pump
speeds of 300–500 ml/min. Such flow rates can be
more readily achieved in tunnelled catheters, which
have larger lumens. If the desired flow rate is not
achieved, the underlying cause needs to be found.
Early dysfunction is usually associated with kinking of
the catheter or a poor position, whilst late dysfunction
is more usually associated with thrombosis, or a fibrin
sheath around the distal end of the catheter.
In an inadequately functioning non-tunnelled
catheter the patient’s position should first be altered.
The catheter should then be flushed with normal
saline, using a 10 ml syringe and reversing the linesconsidered. While line reversal may increase recircula-
tion, this is usually within acceptable limits for short
periods. If all these manoeuvres fail, catheter should
be repositioned or replaced.
For tunnelled catheters, urokinase and low-level
anticoagulation can be considered although there is no
evidence that warfarin prolongs catheter survival.
However, if simple manoeuvres fail, changing the line
over a guide wire may be the best and cheapest
alternative, although it is vital to ensure that it is not
simply repositioned in the same suboptimal position.Bullet Points
% Temporary access to patients circulation
should be undertaken in a planned manner,
such that the route and type of access are
considered in advance, taking into perspec-
tive the patient’s clinical condition and likely
length of time that the access will be required.
% The use of tunnelled catheters carries a
significantly reduced rate of infection and
should be the preferred means of providing
access to circulation for periods in excess of 2
weeks.
% The use of the subclavian route for insertion
of central venous catheters, should be used
with care in patients who may require long
term renal replacement therapy.
% Femoral vein catheters have a high incidence
for the development of thrombosis, and their
management should be according to strict
protocols with the use of anti-embolic pro-
phylaxis from the time of insertion.
% Ultrasound guided insertion of central
venous catheters is now the standard method
for insertion.
% The optimal care of the exit site, in order to
prevent colonisation is of importance in
preventing infection and units with a high
incidence of S. aureus infection should
consider the use of mupirocin ointment on
the exit site with dressing changes.
% The use of antibacterial impregnated cath-
eters, and antibacterial locks, do have a part
to play in prevention of catheter-associated
infection and should be considered in units
with high incidences of infection.
% Early removal of catheters in patients with
blood borne infections is vital to prevent
subsequent complications including osteo-
myelitis, and endocarditis.Eur J Vasc Endovasc Surg Vol 31, April 2006
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